← Leaderboards
Victor Bronshtein
Universal Stabilization Technologies
$6,629,546
Attributed
$6,927,681
Total exposure
9
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1M · FY2006–22$2M$1.5M$1M$500K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$6,705,938 · 8
CDC$221,743 · 1
By mechanism
R44$2,416,419 · 2
R33$1,587,318 · 1
U01$1,194,078 · 1
R21$638,086 · 1
R41$596,270 · 1
R43$495,510 · 3
Top collaborators
- Patricia Veronica Aguilar1 shared
- Douglas M Watts1 shared
Others in their field
Top investigators on “Temperature”
- Gregory S Boebinger · Florida State University$146,179,779
- Alex Lacerda · Florida State University$112,062,456
- Neil S Sullivan · Florida State University$56,415,529
- Arthur S Edison · Florida State University$56,388,138
- Charles H Mielke · Florida State University$55,673,680
- Alan G Marshall · Florida State University$55,673,680
Research focus
TemperatureTechnologyCold ChainsLegal PatentFreeze DryingProductionPhysical Process Of VaporizationLifeBacteriaBiologicalEpidemicBiological PreservationContractsIntestinesVaccinesInfectionInnovationPreparationProbioticsProceduresDrug FormulationsEnvironmentPolymersBase
Grant awards (17)
Thermostable Inactivated Potent Yellow Fever Vaccine$296,890
R41 · FY2022 · AI · contact PI
Thermostable Inactivated Potent Yellow Fever Vaccine$299,380
R41 · FY2021 · AI · contact PI
Development of a thermostable rotavirus vaccine for mucosal delivery withoutneed for reconstitution - Phase II$815,746
R44 · FY2018 · AI · contact PI
Development of a thermostable, electron beam inactivated Sabin-based polio vaccine for mucosal delivery$221,743
R43 · FY2018 · IP · contact PI
Development of a thermostable rotavirus vaccine for mucosal delivery withoutneed for reconstitution - Phase II$454,871
R44 · FY2017 · AI · contact PI
Thermostable vaginal probiotic microbicide$525,814
R33 · FY2015 · AI · contact PI
Development of a thermostable rotavirus vaccine for mucosal delivery without need for reconstitution$147,981
R43 · FY2015 · AI · contact PI
Thermostable vaginal probiotic microbicide$544,412
R33 · FY2014 · AI · contact PI
Thermostable vaginal probiotic microbicide$517,092
R33 · FY2013 · AI · contact PI
Thermostable vaginal probiotic microbicide$305,320
R21 · FY2012 · AI · contact PI
Formulation of Ambient Temperature and Humidity Stable Rabies Vaccines$633,988
R44 · FY2011 · AI · contact PI
Thermostable vaginal probiotic microbicide$332,766
R21 · FY2011 · AI · contact PI
Formulation of Ambient Temperature and Humidity Stable Rabies Vaccines for Oral D$511,814
R44 · FY2010 · AI · contact PI
Stable Micronized Vaccines Against Smallpox and Japanese Encephalitis$446,001
U01 · FY2008 · AI · contact PI
Formulation of Ambient Temperature and Humidity Stable Rabies Vaccines for Oral D$125,786
R43 · FY2008 · AI · contact PI
Stable Micronized Vaccines Against Smallpox and Japanese Encephalitis$316,567
U01 · FY2007 · AI · contact PI
Stable Micronized Vaccines Against Smallpox and Japanese Encephalitis$431,510
U01 · FY2006 · AI · contact PI